;
Skip to main content
Home > Week in Review > Other News

Chronological Index of : Other News

 Current Issue
  • Mimetas, National Center for the Replacement, Radboud University Nijmegen Medical Center, University of Applied Sciences and Arts Northwestern Switzerland supply/service news

    Mimetas B.V., Leiden, the Netherlands National Center for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), London, U.K. Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands …

    Published on 10/13/2014
  • Navidea, NIH diagnostic news

    Navidea Biopharmaceuticals Inc. (NYSE-M:NAVB), Dublin, Ohio National Institutes of Health, Bethesda, Md. Business: Diagnostic Navidea said NIH's NCI awarded the biotech a Small Business Innovation Research (SBIR) …

    Published on 10/13/2014
  • Novo Nordisk endocrine/metabolic news

    Novo Nordisk A/S (CSE:NVO; NYSE:NVO), Bagsvaerd, Denmark Business: Endocrine/Metabolic Novo Nordisk said it will establish a new obesity research unit in Seattle. The unit's main task will be to identify new approaches …

    Published on 10/13/2014
  • Agilent supply/service, diagnostic news

    Agilent Technologies Inc. (NYSE:A), Santa Clara, Calif. Business: Supply/Service, Diagnostic Agilent said its board approved the separation of the company's Keysight Technologies Inc. electronic measurement subsidiary …

    Published on 10/6/2014
  • Auxilium endocrine/metabolic, genitourinary, musculoskeletal news

    Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL), Chesterbrook, Pa. Business: Endocrine/Metabolic, Genitourinary, Musculoskeletal Auxilium will reduce headcount by about 30% to consolidate commercial operations and will …

    Published on 10/6/2014
  • BioCryst, NIH infectious news

    BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX), Durham, N.C. National Institutes of Health, Bethesda, Md. Business: Infectious BioCryst said NIH's National Institute of Allergy and Infectious Disease (NIAID) exercised two …

    Published on 10/6/2014
  • Caliber Biotherapeutics, Mapp Biopharmaceutical, U.S. Department of Health and Human Services infectious news

    Caliber Biotherapeutics LLC, Bryan, Texas Mapp Biopharmaceutical Inc., San Diego, Calif. U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious HHS said it is in talks with biomanufacturing…

    Published on 10/6/2014
  • Chimerix, U.S. Department of Health and Human Services infectious news

    Chimerix Inc. (NASDAQ:CMRX), Durham, N.C. U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious Chimerix said HHS's Biomedical Advanced Research and Development Authority (BARDA) extended …

    Published on 10/6/2014
  • Cytori gene/cell therapy, musculoskeletal news

    Cytori Therapeutics Inc. (NASDAQ:CYTX; Xetra:XMPA), San Diego, Calif. Business: Gene/Cell therapy, Musculoskeletal Cytori will reduce headcount to about 77 from "a peak of 119 earlier this year" and will focus on its U.…

    Published on 10/6/2014
  • Echo Therapeutics diagnostic news

    Echo Therapeutics Inc. (NASDAQ:ECTE), Philadelphia, Pa. Business: Diagnostic Echo said that it suspended its operations to conserve liquidity and capital resources because the company believes that it has insufficient …

    Published on 10/6/2014
  • Regado Biosciences cardiovascular news

    Regado Biosciences Inc. (NASDAQ:RGDO), Basking Ridge, N.J. Business: Cardiovascular Regado said it will reduce headcount by about 60%, or 20 employees, across all operational sites. Regado said that the staff reduction …

    Published on 10/6/2014
  • Vaxine, GlaxoSmithKline, NIH infectious news

    Vaxine Pty. Ltd., Garran, Australia GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. National Institutes of Health, Bethesda, Md. Business: Infectious NIH's National Institute of Allergy and Infectious Diseases (…

    Published on 10/6/2014
  • Baxter pharmaceuticals, biosimilars news

    Baxter International Inc. (NYSE:BAX), Deerfield, Ill. Business: Pharmaceuticals, Biosimilars Baxter said the name of the new public biopharma company that will emerge from the split of its business will be Baxalta Inc. …

    Published on 9/29/2014
  • BioCryst, NIH infectious news

    BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX), Durham, N.C. National Institutes of Health, Bethesda, Md. Business: Infectious BioCryst said NIH's National Institute of Allergy and Infectious Disease (NIAID) modified a …

    Published on 9/29/2014
  • Broad Institute, Harvard Medical School, Icahn School of Medicine at Mount Sinai, NIH, Oregon Health and Science University (OHSU), University of California bioinformatics, computational chemistry ...

    Broad Institute of MIT and Harvard, Cambridge, Mass. Harvard Medical School, Boston, Mass. Icahn School of Medicine at Mount Sinai, New York, N.Y. National Institutes of Health, Bethesda, Md. Oregon Health and Science …

    Published on 9/29/2014
  • Eli Lilly, Takeda endocrine/metabolic news

    Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Business: Endocrine/Metabolic A judge in the U.S. District Court for the Western District of Louisiana issued a…

    Published on 9/29/2014
  • Eutropics, NIH pharmacogenetics news

    Eutropics Pharmaceuticals Inc., Cambridge, Mass. National Institutes of Health, Bethesda, Md. Business: Pharmacogenetics Eutropics said it received a $1.5 million Small Business Innovation Research (SBIR) contract from …

    Published on 9/29/2014
  • Genetic Technologies diagnostic news

    Genetic Technologies Ltd. (ASX:GTG; NASDAQ:GENE), Fitzroy, Australia Business: Diagnostic Genetic Technologies announced plans to restructure and realign activities to focus on the U.S. molecular diagnostics market and …

    Published on 9/29/2014
  • Genocea, Bill & Melinda Gates Foundation infectious news

    Genocea Biosciences Inc. (NASDAQ:GNCA), Cambridge, Mass. Bill & Melinda Gates Foundation, Seattle, Wash. Business: Infectious Genocea received a $1.2 million grant from the Gates Foundation to identify protective T cell…

    Published on 9/29/2014
  • International Progressive MS Alliance autoimmune news

    International Progressive MS Alliance, London, U.K. Business: Autoimmune The International Progressive MS Alliance has awarded its first round of 22 research grants to investigators at research universities and …

    Published on 9/29/2014
  • Novavax, U.S. Department of Health and Human Services infectious news

    Novavax Inc. (NASDAQ:NVAX), Rockville, Md. U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious Novavax said HHS's Biomedical Advanced Research and Development Authority (BARDA) exercised …

    Published on 9/29/2014
  • PharmAthene, NIH infectious news

    PharmAthene Inc. (NYSE-M:PIP), Annapolis, Md. National Institutes of Health, Bethesda, Md. Business: Infectious PharmAthene received a contract worth up to $28.1 million from NIH's National Institute of Allergy and …

    Published on 9/29/2014
  • Silarus Therapeutics Inc., Thyritope Biosciences Inc., GlaxoSmithKline hematology, endocrine/metabolic, autoimmune news

    Silarus Therapeutics Inc., San Diego, Calif. Thyritope Biosciences Inc., San Diego, Calif. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Business: Hematology, Endocrine/Metabolic, Autoimmune Avalon Ventures and …

    Published on 9/29/2014
  • Tekmira, Wellcome Trust infectious news

    Tekmira Pharmaceuticals Corp. (TSX:TKM; NASDAQ:TKMR), Burnaby, B.C. Wellcome Trust, London, U.K. Business: Infectious Tekmira joined a consortium to conduct clinical trials of Ebola virus therapeutics in West Africa. …

    Published on 9/29/2014
  • Tengion gene/cell therapy, transplant news

    Tengion Inc. (OTCQB:TNGN), Winston-Salem, N.C. Business: Gene/Cell therapy, Transplant Regenerative medicine company Tengion hired Jefferies to explore strategic options. Tengion said the decision allows it to realize …

    Published on 9/29/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993